AAAAAA
Results:
1-20
|
Results: 20
Authors:
Dahlof, C
Citation: C. Dahlof, Assessing patient preference in migraine treatment, CEPHALALGIA, 21(8), 2001, pp. 791-795
Authors:
Dahlof, C
Linde, M
Citation: C. Dahlof et M. Linde, One-year prevalence of migraine in Sweden: a population-based study in adults, CEPHALALGIA, 21(6), 2001, pp. 664-671
Authors:
Diener, HC
Tfelt-Hansen, P
de Beukelaar, F
Ferrari, MD
Olesen, J
Dahlof, C
Mathew, N
Citation: Hc. Diener et al., The efficacy and safety of sc Alniditan vs. sc Sumatriptan in the acute treatment of migraine: a randomized, double-blind, placebo-controlled trial, CEPHALALGIA, 21(6), 2001, pp. 672-679
Authors:
Dahlof, C
Citation: C. Dahlof, Clinical efficacy and tolerability of sumatriptan tablet and suppository in the acute treatment of migraine: a review of data from clinical trials, CEPHALALGIA, 21, 2001, pp. 9-12
Authors:
Goadsby,"Lance, J
Ferrari, M
Dahlof, C
Watson, D
Mathew, N
Diener, HC
Goldstein, J
Salonen, R
Messina, E
Rapaport, A
O'Sullivan, E",Saxena,Dowson
Citation: J. Goadsby,"lance et al., Imigran: Ten years of improving the lives of migraine patients - Rome, 24 March 2000 - Questions from the audience, CEPHALALGIA, 21, 2001, pp. 39-41
Authors:
Dahlof, C
Tfelt-Hansen, P
Massiou, H
Fazekas, A
Citation: C. Dahlof et al., Dose finding, placebo-controlled study of oral almotriptan in the acute treatment of migraine, NEUROLOGY, 57(10), 2001, pp. 1811-1817
Authors:
Dahlof, C
Goadsby, PJ
Citation: C. Dahlof et Pj. Goadsby, Ergots - Therapy, MG CLIN NEU, 17, 2000, pp. 66-82
Authors:
Dahlof, C
Lines, C
Citation: C. Dahlof et C. Lines, Rizatriptan - Therapy, MG CLIN NEU, 17, 2000, pp. 162-172
Authors:
Tfelt-Hansen, P
Block, G
Dahlof, C
Diener, HC
Ferrari, MD
Goadsby, PJ
Guidetti, V
Jones, B
Lipton, RB
Massiou, H
Meinert, C
Sandrini, G
Steiner, T
Winter, PBO
Citation: P. Tfelt-hansen et al., Guidelines for controlled trials of drugs in migraine: second edition, CEPHALALGIA, 20(9), 2000, pp. 765-786
Authors:
Linton-Dahlof, P
Linde, M
Dahlof, C
Citation: P. Linton-dahlof et al., Withdrawal therapy improves chronic daily headache associated with long-term misuse of headache medication: a retrospective study, CEPHALALGIA, 20(7), 2000, pp. 658-662
Authors:
Havanka, H
Dahlof, C
Pop, PHM
Diener, HC
Winter, P
Whitehouse, H
Hassani, H
Citation: H. Havanka et al., Efficacy of naratriptan tablets in the acute treatment of migraine: A dose-ranging study, CLIN THER, 22(8), 2000, pp. 970-980
Authors:
Tfelt-Hansen, P
Saxena, PR
Dahlof, C
Pascual, J
Lainez, M
Henry, P
Diener, HC
Schoenen, J
Ferrari, MD
Goadsby, PJ
Citation: P. Tfelt-hansen et al., Ergotamine in the acute treatment of migraine - A review and European consensus, BRAIN, 123, 2000, pp. 9-18
Authors:
Peikert, A
Becker, WJ
Ashford, EA
Dahlof, C
Hassani, H
Salonen, RJ
Citation: A. Peikert et al., Sumatriptan nasal spray: a dose-ranging study in the acute treatment of migraine, EUR J NEUR, 6(1), 1999, pp. 43-49
Authors:
Dahlof, C
Citation: C. Dahlof, Almotriptan - A viewpoint, CNS DRUGS, 11(2), 1999, pp. 166-166
Authors:
Thulin, T
Lehtonen, A
Dahlof, C
Nilsson-Ehle, P
Engqvist, L
Lagerstedt, C
Berglund, E
Citation: T. Thulin et al., Long-term effects of diltiazem and atenolol on blood glucose, serum lipids, and serum urate in hypertensive patients, INT J CL PH, 37(1), 1999, pp. 28-33
Authors:
Dahlof, C
Citation: C. Dahlof, Sumatriptan nasal spray in the acute treatment of migraine: a review of clinical studies, CEPHALALGIA, 19(9), 1999, pp. 769-778
Authors:
Dahlof, C
Citation: C. Dahlof, How to assess patient preference of migraine treatments, CEPHALALGIA, 19, 1999, pp. 2-6
Authors:
Dahlof, C
Citation: C. Dahlof, Indirect cost of migraine, CEPHALALGIA, 19(1), 1999, pp. 1-1
Authors:
Dahlof, C
Citation: C. Dahlof, Safety and tolerability of the novel 5-HT1B/1D agonist rizatriptan in migraineurs, HEADACHE, 39, 1999, pp. S16-S18
Authors:
Dahlof, C
Citation: C. Dahlof, The SF-36 and the assessment of HRQoL, CEPHALALGIA, 18(9), 1998, pp. 592-592
Risultati:
1-20
|